NCT07003958 The Effect of Different Deproteinizing Agents on the Clinical Success of Fissure Sealants in Primary Teeth
| NCT ID | NCT07003958 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tokat Gaziosmanpasa University |
| Condition | Fissure Sealant |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-08-05 |
| Primary Completion | 2026-08-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-08-05 with a primary completion date of 2026-08-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Investigation of the effect of deproteinization agents on the clinical success of non-invasive fissure sealant application, which is a non-invasive method used to prevent caries formation or to stop the progression of initial caries lesions limited to enamel on tooth surfaces thought to be at high risk of caries.
Eligibility Criteria
Inclusion Criteria: * Patients between the ages of 4-6 who do not have any systemic problems * Have a score of 3 and 4 on the Frankl Behavior Scale * Do not have a habit of clenching and/or grinding their teeth * Have lower second primary molars without caries * Have an indication for fissure sealant application Exclusion Criteria: * Teeth with fissure sealants * Teeth with developmental defects such as hypoplasia * Teeth with approximal or incipient caries lesions on one or both mandibular second primary molars
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07003958 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 6 Years, studying Fissure Sealant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07003958 currently recruiting?
Yes, NCT07003958 is actively recruiting participants. Contact the research team at alemcosgun@hotmail.com for enrollment information.
Where is the NCT07003958 trial being conducted?
This trial is being conducted at Tokat Province, Turkey (Türkiye).
Who is sponsoring the NCT07003958 clinical trial?
NCT07003958 is sponsored by Tokat Gaziosmanpasa University. The trial plans to enroll 60 participants.